Wild E J, Tabrizi S J. Therapies targeting DNA and RNA in Huntington's disease. Lancet Neurol 2017; 16: 837–47—In table 1, the final row and footnote have been updated to reflect that CHDI Foundation's small-molecule huntingtin-lowering programme is currently at the screening stage and that the mechanisms of action, route of delivery, and advantages and disadvantages of the small molecules being investigated remain to be determined. This correction has been made to the online version as of Nov 14, 2017.

中文翻译：

---

更正

Wild EJ，Tabrizi S J.针对亨廷顿氏病的DNA和RNA的疗法。柳叶刀神经科学2017; 16： 837-47 —在表1中，最后一行和脚注已更新，以反映CHDI基金会的降低小分子亨廷顿蛋白计划目前处于筛选阶段，其作用机制，传递途径以及优势和优势小分子被研究的缺点尚待确定。截至2017年11月14日，已对在线版本进行了更正。